Barbara Ryan
Barbara Ryan
Barbara Ryan Colemanis a fictional character from the American CBS soap opera As the World Turns. In the early 1970s, Barbara was played by a succession of actresses, but the actress most associated with the role is Colleen Zenk, who played her since September 1, 1978. Better known as simply Barbara Ryan she is portrayed as a heroine who experienced many tragedies, mostly at the hands of her controlling ex-husband, the villainous James Stenbeck...
creating otherwise
Otherwise you are just creating a stalemate. Shareholders want to know who is going to be in charge.
bristol corporate good government grab perspective posture since sort statement taking trying victory
I think it's sort of a meaningless statement from their perspective and they're trying to grab victory out of this by taking a posture that makes them look altruistic, ... I also think they're trying to look like they're being good corporate citizens. Since Bristol has been investigated by just about every government agency, they have a lot to make up for in that regard.
change extremely position surprised
I would say that Merck's been so adamant in its position that I would be extremely surprised if they change their position after only two cases.
benefit lose money
Merck and Pfizer would probably lose money from a moratorium. They have portfolios that would benefit from DTC advertising.
benefit lose money
Merck and Pfizer would probably lose money from a moratorium, ... They have portfolios that would benefit from DTC advertising.
betting companies innovative pipeline worse
Lilly has been more innovative than most other companies but done worse at execution. There's betting on a pipeline that hasn't panned out in the past.
change higher people point
It doesn't change much. But it does point people to the higher end of the range.
fold months street telling tent three waiting wall
Three months ago, Wall Street was telling Pfizer to fold up its tent and go home. Now some of the things we've been waiting for are coming.
currently fairly peers portfolio relative standing
Wyeth is really standing out relative to its peers currently because it has a fairly young portfolio of new drugs,
company heads left management problems roll vulnerable zero
We're left with a company with a litany of problems and a management that has zero credibility. I think some heads will roll and they will be very vulnerable to take-out.
clear company growth vehicle view
The only company which is a clear growth vehicle in our view is Schering-Plough.
obviously people vaccine
If it's universally recommended then obviously people are going to be getting the vaccine much more broadly.
below brands generally key sales
Fourth-quarter 2005 sales of key brands were generally below our forecasts.
based cost earnings expect recovery year
Bristol-Myers earnings will be down this year but then we expect to see a recovery based on the introduction of new drugs and cost cuts.